ARCHIVES

Micafungin Bests Fluconazole In Phase III Antifungal Trial

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

Lymphoblastoid If Test Shows Toxicity Not From Impurity, Investigator Says

August 8, 1980

NCI Awards $6.7 Million For Breast Cancer Research.

September 8, 2000

In Brief: House, Senate Pass Rescision Bills; NCI Compromise Figure Probably About $10 Million Cut For FY 1981

May 29, 1981

Dalton To Head Moffitt Cancer Center; HHS Appoints Gerberding CDC Director

July 12, 2002

Duke Scores Highest On NCAB Review

July 14, 1978

Advisers Fume Over Preventions Budget Cut; NIH Probably Did It

May 22, 1992